Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-effect study of Wenxin Granules for atrial premature beats
ChiCTR2100041644Phase 4Recruiting
- Sponsor
- China Academy of Chinese Medical Sciences
- Start
- Jan 2021
- Countries
- 1
01
Overview
Phase 4, open-label trial of wenxin keli in atrial extrasystole (AES) (4 arms), sponsored by China Academy of Chinese Medical Sciences. Primary endpoints: Responder rate based on 24-hour Holter monitoring and Change in Traditional Chinese Medicine Syndrome Score from baseline. Started Jan 2021; status: recruiting.
02
Drugs
wenxin keli
03
Conditions
atrial extrasystole (AES)
Beyond the preview
Go deeper on ChiCTR2100041644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041644.